These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 10529381)
1. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels. Walker GR; Watkins T; Ansevin CF Biochem Biophys Res Commun; 1999 Oct; 264(2):430-5. PubMed ID: 10529381 [TBL] [Abstract][Full Text] [Related]
2. Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients. Watkins TC; Zelinka LM; Kesic M; Ansevin CF; Walker GR J Cell Biochem; 2006 Sep; 99(1):79-87. PubMed ID: 16598745 [TBL] [Abstract][Full Text] [Related]
3. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Vernino S; Lennon VA Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293 [TBL] [Abstract][Full Text] [Related]
4. Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two. Schoser B; Jacob S; Hilton-Jones D; Müller-Felber W; Kubisch C; Claus D; Goebel HH; Vita G; Vincent A; Toscano A; Van den Bergh P Neuromuscul Disord; 2009 Mar; 19(3):223-8. PubMed ID: 19208478 [TBL] [Abstract][Full Text] [Related]
5. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Romi F; Skeie GO; Gilhus NE; Aarli JA Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509 [TBL] [Abstract][Full Text] [Related]
6. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis]. Wilisch A; Schultz A; Greiner A; Kirchner T; Müller-Hermelink HK; Marx A Verh Dtsch Ges Pathol; 1996; 80():261-6. PubMed ID: 9065023 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune myasthenia gravis in childhood. Andrews PI Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Suzuki S; Utsugisawa K; Yoshikawa H; Motomura M; Matsubara S; Yokoyama K; Nagane Y; Maruta T; Satoh T; Sato H; Kuwana M; Suzuki N Arch Neurol; 2009 Nov; 66(11):1334-8. PubMed ID: 19752287 [TBL] [Abstract][Full Text] [Related]
9. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. Suzuki S; Satoh T; Yasuoka H; Hamaguchi Y; Tanaka K; Kawakami Y; Suzuki N; Kuwana M J Neuroimmunol; 2005 Dec; 170(1-2):141-9. PubMed ID: 16182377 [TBL] [Abstract][Full Text] [Related]
10. Nature and Action of Antibodies in Myasthenia Gravis. Ruff RL; Lisak RP Neurol Clin; 2018 May; 36(2):275-291. PubMed ID: 29655450 [TBL] [Abstract][Full Text] [Related]
13. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis. Stickler DE; Stickler LL Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882 [TBL] [Abstract][Full Text] [Related]
14. Incidence and reactivity patterns of skeletal and heart (SH) reactive autoantibodies in the sera of patients with myasthenia gravis. Connor RI; Lefvert AK; Benes SC; Lang RW J Neuroimmunol; 1990 Feb; 26(2):147-57. PubMed ID: 2298883 [TBL] [Abstract][Full Text] [Related]